PHARMACYTE BIOTECH, INC. Proceeds from Issuance of Convertible Preferred Stock
PHARMACYTE BIOTECH, INC. (PMCB) reported Proceeds from Issuance of Convertible Preferred Stock of $6.18 million for the 12-month period ending 2026-04-30, per its 10-K filed 2026-07-29.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock · last filed 2026-07-29
- PHARMACYTE BIOTECH, INC. proceeds from issuance of convertible preferred stock for the quarter ending 2026-04-30 was -$86.42K.
- PHARMACYTE BIOTECH, INC. proceeds from issuance of convertible preferred stock for the quarter ending 2026-01-31 was $0.00.
- PHARMACYTE BIOTECH, INC. proceeds from issuance of convertible preferred stock for the quarter ending 2025-04-30 was $0.00.
- PHARMACYTE BIOTECH, INC. proceeds from issuance of convertible preferred stock for the quarter ending 2025-01-31 was $0.00.
- PHARMACYTE BIOTECH, INC. proceeds from issuance of convertible preferred stock for fiscal 2026 was $6.18M.
- PHARMACYTE BIOTECH, INC. proceeds from issuance of convertible preferred stock for fiscal 2025 was $0.00.
| Period end | Proceeds from Issuance of Convertible Preferred Stock 3 month | Proceeds from Issuance of Convertible Preferred Stock 6 month | Proceeds from Issuance of Convertible Preferred Stock 9 month | Proceeds from Issuance of Convertible Preferred Stock 12 month |
|---|---|---|---|---|
| 2026-04-30 | -$86.42K derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-29 | -$86.42K derived: sum of 2 quarters · filed 2026-07-29 | $6.18M 10-K · filed 2026-07-29 | |
| 2026-01-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2026-03-17 | $6.27M 10-Q · filed 2026-03-17 | ||
| 2025-10-31 | $6.27M 10-Q · filed 2025-12-18 | |||
| 2025-04-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-29 | $0.00 derived: sum of 2 quarters · filed 2026-07-29 | $0.00 10-K · filed 2026-07-29 | |
| 2025-01-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2026-03-17 | $0.00 10-Q · filed 2026-03-17 | ||
| 2024-10-31 | $0.00 10-Q · filed 2025-12-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |